Drugs and Behavior - Vocabulary Flashcards (Exam 1 Study Guide)

0.0(0)
studied byStudied by 0 people
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/56

flashcard set

Earn XP

Description and Tags

Key terms and concepts from Chapters 1-5 (Introduction to drug use through Drug Action) covered in the lecture notes, focusing on definitions and core ideas for exam preparation.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

57 Terms

1
New cards

Tolerance

A state in which repeated exposure to a drug reduces its effects, requiring larger doses for the same effect.

2
New cards

Pharmacokinetic tolerance

Tolerance due to changes in drug metabolism or disposition that reduce the drug’s effect.

3
New cards

Pharmacodynamic tolerance

Tolerance resulting from changes in the nervous system, such as receptor down-regulation or changes in receptor sensitivity.

4
New cards

Behavioral tolerance

Tolerance developed through learning and adaptation to the drug’s effects, reducing impairment.

5
New cards

Withdrawal

A cluster of symptoms that occur when a dependent user stops taking a drug.

6
New cards

Dependence

A state in which drug use becomes frequent and stopping is difficult, often with withdrawal symptoms.

7
New cards

Drug misuse

Using drugs or chemicals in greater amounts or for longer than prescribed, or for non-medical reasons.

8
New cards

Drug abuse

Use that causes social, occupational, psychological, or physical problems.

9
New cards

Gateway substances

Early indicators of a pattern of future drug use; not necessarily causal for later drug use.

10
New cards

Correlate

A variable that is related to another variable; correlation does not imply causation.

11
New cards

Correlation

A relationship where two factors move together; does not prove one causes the other.

12
New cards

Antecedent

A factor that occurs before initiation of drug use and can help explain relationships, though not necessarily causal.

13
New cards

Gateway substances as antecedents

Substances that may signal a pattern of future drug use rather than directly causing it.

14
New cards

Incentive Salience

Craving or wanting; the motivational 'wanting' attributed to drug cues, often subconscious.

15
New cards

Negative Affect

Depression, anxiety, and negative thoughts that can influence drug use.

16
New cards

Executive Function

Self-control and long-term decision-making abilities that can affect drug use and relapse.

17
New cards

Neuron

Nerve cell that transmits information; about 85–100 billion in the brain; has dendrites, cell body, axon, and axon terminals.

18
New cards

Glia

these cells that provide support, nutrients, waste removal, myelin, and the blood-brain barrier; make up most brain cells. Provides firmenss and structure to the brain (and make up 90% of it)

19
New cards

Dendrites

Branch-like structures that receive signals from other neurons.

20
New cards

Cell body (soma)

Contains the nucleus; integrates and interprets signals.

21
New cards

Axon

Long projection that conducts electrical impulses to the axon terminals.

22
New cards

Axon terminals

end-tufts that release neurotransmitters into the synapse.

23
New cards

Synapse

The gap between neurons where neurotransmitters are released to transfer signals.

24
New cards

Neurotransmitters

Chemical messengers that transmit signals across the synapse; major ones include dopamine, serotonin, norepinephrine, GABA, and endogenous opioids.

25
New cards

Dopamine

Neurotransmitter involved in pleasure and reward; many drugs increase this neurotransmitter in the reward pathway.

26
New cards

Serotonin

Neurotransmitter involved in mood, sleep, and sexual desire; affected by MDMA and LSD.

27
New cards

Norepinephrine

Neurotransmitter involved in arousal and attention; part of the fight/flight response.

28
New cards

GABA

Primary inhibitory neurotransmitter; reduces neuronal activity; targeted by alcohol and benzodiazepines.

29
New cards

Endogenous opioids

Natural opioid peptides (endorphins) involved in analgesia and reward.

30
New cards

Blood-brain barrier

Protective barrier that restricts passage of many substances from blood into the brain.

31
New cards

Autonomic Nervous System

Regulates involuntary actions; contains sympathetic and parasympathetic branches.

32
New cards

Sympathetic nervous system

Fight-or-flight branch; increases arousal (e.g., heart rate via norepinephrine).

33
New cards

Parasympathetic nervous system

Rest-and-digest branch; promotes relaxation and energy conservation (acetylcholine).

34
New cards

Somatic Nervous System

Controls voluntary movements and conveys sensory information to the CNS.

35
New cards

Central Nervous System

Brain and spinal cord; integrates information, learning, memory, and coordinated activity.

36
New cards

Agonist

A drug that mimics a neurotransmitter and activates the receptor.

37
New cards

Antagonist

A drug that binds to a receptor but does not activate it, blocking the neurotransmitter.

38
New cards

Synthesis (neurotransmitter)

Production of a neurotransmitter from precursor molecules.

39
New cards

Storage (neurotransmitter)

Packaging of neurotransmitters into synaptic vesicles for release.

40
New cards

Release (neurotransmitter)

Release of neurotransmitters into the synapse in response to an action potential.

41
New cards

Reuptake

Reabsorption of neurotransmitters back into the presynaptic neuron.

42
New cards

Metabolism (neurotransmitter)

Enzymatic breakdown of neurotransmitters, reducing their activity.

43
New cards

Dose-Response Curve

Graph of the size of a response to the amount of drug administered; threshold is the first observable effect; ceiling is the maximum effect.

44
New cards

LD50

Lethal dose for 50% of subjects in a test; a standard measure of toxicity.

45
New cards

Routes of administration

Ways of taking drugs: inhalation (smoking), injection, intranasal (snorting), oral (ingestion), subcutaneous, transdermal, etc.

46
New cards

Naloxone

Opioid receptor antagonist used to reverse opioid overdose.

47
New cards

Safety margin

Difference between the dose that produces the desired effect and the dose that causes unacceptable adverse effects.

48
New cards

Enzyme induction

Increased production of drug-metabolizing enzymes, leading to faster drug metabolism and reduced effects.

49
New cards

Drug deactivation

Ways a drug can stop working: unchanged elimination, metabolic change, or antagonism (e.g., naloxone) reducing activity.

50
New cards

Double-blind

Study design in which neither participants nor researchers know who receives the drug versus placebo.

51
New cards

Placebo

An inert substance used as a control; expectancy effects can produce real perceived changes.

52
New cards

Specific effects

Pharmacological effects produced by the drug’s interaction with receptors.

53
New cards

Nonspecific effects

Effects arising from expectations, context, or placebo rather than the drug’s pharmacology.

54
New cards

Categories of drugs (stimulants, depressants, opioids, hallucinogens/psychedelics, psychotherapeutics)

Major broad classes used to categorize drugs by their primary effects on the CNS.

55
New cards

Cocaine

Stimulant derived from the coca plant; blocks reuptake of dopamine, norepinephrine, and serotonin; commonly used in powder or crack forms; short half-life (~1 hour).

56
New cards

Fastest to slowest ways to get high

  1. Inhalation

  2. Intravenous (injection)

  3. Insufflation (snorting)

  4. Intramuscular injection

  5. Subcutaneous (placed on the skin)

  6. Oral ingestion (eating)

57
New cards

Ataxia

Impaired coordination